A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted ...

In a key secondary endpoint, 31.6% of people taking tirzepatide achieved at least 25% body weight loss compared ... ahead of Wegovy with $19.4 billion, while the versions of the drug to treat ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other ... popularity after the Food and Drug Administration approved ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage study of its investigational candidate, amycretin, in overweight/obese ...

Fresh questions are being asked about the use of weight loss injections ... of Wegovy. The two biggest selling GLP-1 drugs are branded as Wegovy or Ozempic - both the same drug semaglutide but ...